Literature DB >> 10723543

Ultrasonic surfactant nebulization with different exciting frequencies.

M H Wagner1, S Wiethoff, W Friedrich, I Mollenhauer, M Obladen, U Boenick.   

Abstract

Intratracheal bolus instillation of natural lung surfactant is the treatment of choice in neonatal respiratory distress syndrome and an increasing part in adults' therapy. For reasons of hemodynamics, surfactant distribution and efficiency the application mode should be improved. Nebulization seems to have some advantages but its technical realization is difficult. The aim of the present study was to investigate if ultrasonic nebulization with exciting frequencies higher than 2.8 MHz can improve the efficiency of surfactant nebulization without changing the surface-active properties of the material. Exciting frequencies of 1.7, 3.3 and 4.0 MHz were used to produce a surfactant aerosol. The phospholipid content in the liquefied aerosol and particle size distinctly dropped with higher frequencies. The surface activity was not altered in the produced aerosol and neither in the surfactant remaining in the nebulizer. Although possible, ultrasonic nebulization of surfactant suspensions is ineffective because of a striking decrease in phospholipid content.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10723543     DOI: 10.1016/s0301-4622(99)00144-1

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  3 in total

1.  Tracheal acid or surfactant instillation raises alveolar surface tension.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2018-05-17

Review 2.  Surfactant therapy: the current practice and the future trends.

Authors:  Khalid Altirkawi
Journal:  Sudan J Paediatr       Date:  2013

3.  Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial.

Authors:  Stefan Minocchieri; Clare A Berry; J Jane Pillow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2018-07-26       Impact factor: 5.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.